BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 16870832)

  • 1. MYPT1 mutants demonstrate the importance of aa 888-928 for the interaction with PKGIalpha.
    Given AM; Ogut O; Brozovich FV
    Am J Physiol Cell Physiol; 2007 Jan; 292(1):C432-9. PubMed ID: 16870832
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MYPT1 protein isoforms are differentially phosphorylated by protein kinase G.
    Yuen S; Ogut O; Brozovich FV
    J Biol Chem; 2011 Oct; 286(43):37274-9. PubMed ID: 21890627
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of myosin phosphatase isoforms in cGMP-mediated smooth muscle relaxation.
    Khatri JJ; Joyce KM; Brozovich FV; Fisher SA
    J Biol Chem; 2001 Oct; 276(40):37250-7. PubMed ID: 11486008
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential phosphorylation of LZ+/LZ- MYPT1 isoforms regulates MLC phosphatase activity.
    Yuen SL; Ogut O; Brozovich FV
    Arch Biochem Biophys; 2014 Nov; 562():37-42. PubMed ID: 25168281
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vascular reactivity in heart failure: role of myosin light chain phosphatase.
    Karim SM; Rhee AY; Given AM; Faulx MD; Hoit BD; Brozovich FV
    Circ Res; 2004 Sep; 95(6):612-8. PubMed ID: 15321927
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Unzipping the role of myosin light chain phosphatase in smooth muscle cell relaxation.
    Huang QQ; Fisher SA; Brozovich FV
    J Biol Chem; 2004 Jan; 279(1):597-603. PubMed ID: 14530290
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Degradation of leucine zipper-positive isoform of MYPT1 may contribute to development of nitrate tolerance.
    Dou D; Ma H; Zheng X; Ying L; Guo Y; Yu X; Gao Y
    Cardiovasc Res; 2010 Apr; 86(1):151-9. PubMed ID: 19939965
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Direct binding and regulation of RhoA protein by cyclic GMP-dependent protein kinase Iα.
    Kato M; Blanton R; Wang GR; Judson TJ; Abe Y; Myoishi M; Karas RH; Mendelsohn ME
    J Biol Chem; 2012 Nov; 287(49):41342-51. PubMed ID: 23066013
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of myosin phosphatase by a specific interaction with cGMP- dependent protein kinase Ialpha.
    Surks HK; Mochizuki N; Kasai Y; Georgescu SP; Tang KM; Ito M; Lincoln TM; Mendelsohn ME
    Science; 1999 Nov; 286(5444):1583-7. PubMed ID: 10567269
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Probing the interaction between the coiled coil leucine zipper of cGMP-dependent protein kinase Ialpha and the C terminus of the myosin binding subunit of the myosin light chain phosphatase.
    Sharma AK; Zhou GP; Kupferman J; Surks HK; Christensen EN; Chou JJ; Mendelsohn ME; Rigby AC
    J Biol Chem; 2008 Nov; 283(47):32860-9. PubMed ID: 18782776
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Myosin phosphatase isoform switching in vascular smooth muscle development.
    Payne MC; Zhang HY; Prosdocimo T; Joyce KM; Koga Y; Ikebe M; Fisher SA
    J Mol Cell Cardiol; 2006 Feb; 40(2):274-82. PubMed ID: 16356512
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interactions between the leucine-zipper motif of cGMP-dependent protein kinase and the C-terminal region of the targeting subunit of myosin light chain phosphatase.
    Lee E; Hayes DB; Langsetmo K; Sundberg EJ; Tao TC
    J Mol Biol; 2007 Nov; 373(5):1198-212. PubMed ID: 17904578
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular Screen Identifies Cardiac Myosin-Binding Protein-C as a Protein Kinase G-Iα Substrate.
    Thoonen R; Giovanni S; Govindan S; Lee DI; Wang GR; Calamaras TD; Takimoto E; Kass DA; Sadayappan S; Blanton RM
    Circ Heart Fail; 2015 Nov; 8(6):1115-22. PubMed ID: 26477830
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cyclic GMP-dependent protein kinase Ialpha inhibits thrombin receptor-mediated calcium mobilization in vascular smooth muscle cells.
    Christensen EN; Mendelsohn ME
    J Biol Chem; 2006 Mar; 281(13):8409-16. PubMed ID: 16446362
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A myosin phosphatase targeting subunit isoform transition defines a smooth muscle developmental phenotypic switch.
    Dirksen WP; Vladic F; Fisher SA
    Am J Physiol Cell Physiol; 2000 Mar; 278(3):C589-600. PubMed ID: 10712248
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nitric oxide-induced biphasic mechanism of vascular relaxation via dephosphorylation of CPI-17 and MYPT1.
    Kitazawa T; Semba S; Huh YH; Kitazawa K; Eto M
    J Physiol; 2009 Jul; 587(Pt 14):3587-603. PubMed ID: 19470783
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Losartan decreases p42/44 MAPK signaling and preserves LZ+ MYPT1 expression.
    Ararat E; Brozovich FV
    PLoS One; 2009; 4(4):e5144. PubMed ID: 19357768
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dimerization of cGMP-dependent protein kinase 1alpha and the myosin-binding subunit of myosin phosphatase: role of leucine zipper domains.
    Surks HK; Mendelsohn ME
    Cell Signal; 2003 Oct; 15(10):937-44. PubMed ID: 12873707
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The involvement of phosphorylation of myosin phosphatase targeting subunit 1 (MYPT1) and MYPT1 isoform expression in NO/cGMP mediated differential vasoregulation of cerebral arteries compared to systemic arteries.
    Lubomirov LT; Papadopoulos S; Filipova D; Baransi S; Todorović D; Lake P; Metzler D; Hilsdorf S; Schubert R; Schroeter MM; Pfitzer G
    Acta Physiol (Oxf); 2018 Sep; 224(1):e13079. PubMed ID: 29694711
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The potential role of MLC phosphatase and MAPK signalling in the pathogenesis of vascular dysfunction in heart failure.
    Ogut O; Brozovich FV
    J Cell Mol Med; 2008 Dec; 12(6A):2158-64. PubMed ID: 19120700
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.